Monovalent Pneumococcal Conjugate(Pfizer)

N/A

Report date: 2024/01/05 16:13:24

Base Information

Drug NameMonovalent Pneumococcal Conjugate(Pfizer)

Drug Alias NamemPnC

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Univalent vaccineVaccines > Development/production technology > Conjugated vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsPneumonia, Pneumococcal

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryPolandFinland

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesPfizer Inc

China Registration ClassN/A

Develop Information

Active CompaniesPfizer Inc

Inactive CompaniesN/A

Active IndicationsPneumonia, Pneumococcal

Inactive IndicationsN/A

Other Information

ATC CodeN/A